Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nexgel (NXGL) Other financing activities (2023 - 2025)

Nexgel posted quarterly Other financing activities of $383000.0 for Q4 2025, up 303.16% year-on-year from $95000.0 in Q4 2024, and up 303.16% on a QoQ basis from $95000.0 in Q4 2024.

Nexgel (NXGL) has 3 years of Other financing activities data on file, last reported at $383000.0 in Q4 2025.

  • For the quarter ending Q4 2025, Other financing activities rose 303.16% year-over-year to $383000.0; the trailing twelve-month figure through Dec 2025 stood at $599000.0 (up 144.49% YoY), and the FY2025 full-year result was $475000.0, up 69.64% from the prior year.
  • Other financing activities for Q4 2025 stood at $383000.0, up from $95000.0 in the prior quarter.
  • Across five years, Other financing activities topped out at $383000.0 in Q4 2025 and bottomed at $29000.0 in Q2 2023.
  • The 3-year median for Other financing activities is $67000.0 (2023), against an average of $125600.0.
  • Peak annual rise in Other financing activities reached 303.16% in 2025, while the deepest fall reached 303.16% in 2025.
  • A 3-year view of Other financing activities shows it stood at $67000.0 in 2023, then jumped by 41.79% to $95000.0 in 2024, then surged by 303.16% to $383000.0 in 2025.
  • The last three Other financing activities figures came in at $383000.0 (Q4 2025), $95000.0 (Q4 2024), and $54000.0 (Q1 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn
10 Nexgel 31,199.58 -1.34 Mn 819,000.00

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 383,000.00
Dec 31, 2025 383,000.00
Dec 31, 2024 95,000.00
Dec 31, 2024 95,000.00
Mar 31, 2024 54,000.00
Mar 31, 2024 54,000.00
Sep 30, 2023 67,000.00
Sep 30, 2023 67,000.00
Jun 30, 2023 29,000.00
Jun 30, 2023 29,000.00